Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeadaches are a recognised side effect of Wegovy (semaglutide), listed in the medicine's Patient Information Leaflet and reported in the STEP clinical trials. They tend to appear in the first few weeks of treatment or after a dose increase, and for most people they ease off as the body adjusts. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses suitability and discusses side effects like this one before treatment begins. If you're already taking Wegovy and headaches are bothering you, the explanation is usually straightforward — though a small number of cases do warrant prompt medical advice, which this page covers clearly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing people assume when headaches start on Wegovy is that something has gone wrong, that the medicine is reacting badly with their body, or that it simply isn't right for them. That conclusion is worth questioning. The full Wegovy side-effect profile is dominated by gastrointestinal symptoms, but headaches appear consistently in trial data too, and they are classified as common, meaning they affect somewhere between one in ten and one in hundred users. Their appearance doesn't signal a problem with the medicine's action; it usually signals the body adjusting to a new hormonal signal.
Semaglutide works on GLP-1 receptors involved in appetite regulation, insulin release and gastric emptying. That slower gastric emptying is what drives a lot of the nausea people experience, and nausea often leads to reduced eating and drinking. Mild dehydration is one of the most plausible explanations for headaches early in treatment, and it is correctable. The NHS medicines page for semaglutide lists headache among the common effects, alongside the gastrointestinal cluster, and frames both as generally transient.
Timing matters here. Headaches that arrive in the first one to two weeks at a new dose, then settle, fit the adjustment pattern. Headaches that persist at the same dose for more than two to three weeks, or that feel different in character from anything you've had before, sit in a different category and are worth raising with a clinician.
Several overlapping mechanisms can contribute. Reduced calorie intake changes blood glucose variability, which some people experience as a headache trigger. Nausea suppressing appetite means fluid intake often drops without the person noticing. Sleep can be disrupted early in treatment, and poor sleep is a reliable headache cause in its own right. None of these are signs of serious harm; they are side effects of a biological adjustment.
Practical steps that many people find useful: drinking steadily throughout the day rather than playing catch-up in the evening, eating small protein-containing meals even when appetite is low, and avoiding the easy habit of replacing food with caffeine. If over-the-counter pain relief is appropriate for you generally, paracetamol or ibuprofen can be used as you normally would, subject to any other medical conditions, but checking with your prescriber or pharmacist first is sensible. You can read answers to common questions about managing treatment on our FAQ page.
The pattern of headaches on semaglutide discussed in clinical guidance suggests that most resolve without dose adjustment. If they're consistently disrupting daily life, that conversation belongs with your prescriber, not with a dose-reduction decision made unilaterally, which can affect the treatment's effectiveness.
Most Wegovy headaches are a nuisance. A minority are a signal. The features that warrant same-day or emergency medical assessment are the same ones that apply regardless of what medicine you're taking.
Call 999 or go to A&E for a headache that is thunderclap, severe onset within seconds, the worst you've ever had. Headache combined with vision changes, weakness on one side of the body, difficulty speaking, or facial drooping requires emergency assessment. These features have nothing to do with Wegovy's mechanism; they describe potential neurological emergencies that need ruling out immediately.
Contact your GP or prescriber promptly (same day, not next week) for: a headache that has lasted more than a few days without any improvement; a headache accompanied by a stiff neck and sensitivity to light; a headache alongside severe upper abdominal pain that radiates to the back, with or without vomiting, that combination may suggest pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines. If you've been wondering whether Wegovy causes headaches and what that means for your health, or whether Wegovy can give you headaches based on how the medicine works, both questions are covered in our related pages alongside less common presentations. For a broader look at how headaches relate to semaglutide across different doses and formulations, that topic is covered in its own dedicated page.
If you suspect a side effect is serious or unexpected, you can report it directly to the MHRA through the Yellow Card scheme. Patients as well as clinicians can submit reports, and doing so helps the regulator build a better picture of real-world safety data for medicines like Wegovy.
If you're thinking about starting Wegovy and headaches are a concern, the right place to raise that is a consultation with a prescriber, not a forum thread. A prescriber can weigh your personal history, any existing headache conditions, and other medicines you take, before treatment begins. At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber, and that review includes a discussion of your likely side-effect profile and what to watch for.
Once approved, your treatment is dispatched the same working day (order before 12pm Monday to Friday) and arrives via DPD next working day in plain, unbranded packaging, nothing on the outside signals what's inside. Our prescribers remain available for aftercare seven days a week, so if headaches or anything else comes up once you're mid-course, there is a clinical team to contact, not just a help-desk email. You can explore the full Wegovy treatment page or go straight to the consultation if you'd like a prescriber to assess your suitability. Side effects like headaches are part of that assessment, not something left to figure out alone.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.